Why the study?
Substantial new heart failure data were published after the 2016 European Society of Cardiology guidelines, with the next formal guideline update not expected before 2021, motivating a clinical practice update summarizing expert consensus on recent developments.
Supports individualized HF management with listed therapies; leaves open need for updated RCTs and contemporary validation.
Autoři původniho textu v plnem zněni: Petar M. Seferovic, Piotr Ponikowski jmenem Heart Failure Association of the European Society of Cardiology.
No takes yet. Share an insight, caveat, or question.
Špinar et al. (2019) conducted a review in Heart Failure. Pharmacotherapy, procedures, devices, and patient management strategies for heart failure was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: